Fairvalue-Calculator Fairvalue-Calculator
EN DE

Synergy Innovation Co (048870) Fair Value & Analysis

Healthcare · KR · Market cap 168B KRW

Price1,667 KRW
Fair Value2,469 KRW
Upside+48.1%
Quality80/100
Evidence: Medium Range 1,620 KRW – 3,317 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Synergy Innovation Co (048870) currently trades at 1,667 KRW, while our model-based Fair Value estimate is 2,469 KRW — implying the stock looks roughly 48.1% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Synergy Innovation Co (048870) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,469 KRW versus a price of 1,667 KRW — about +48% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 048870?
Our 21-model fair value for Synergy Innovation Co is 2,469 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 1,667 KRW.
What is the quality score of 048870?
Synergy Innovation Co has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.